Nordhealth AS (OSL:NORDH) Beneish M-Score: -3.29 (As of Jun. 30, 2026)


OSL:NORDH Nordhealth AS OSL:NORDH
75 GF Score
Price kr25.60
GF Value kr38.75
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Nordhealth AS Beneish M-Score?

Nordhealth AS OSL:NORDH 75 Beneish M-Score is -3.29 as of Jun. 30, 2026. GuruFocus rates OSL:NORDH with a GF Score™ of 75/100 and a GF Value™ of kr38.75 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 630 Healthcare Providers & Services companies, Nordhealth AS ranks better than 86.03% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.29 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Nordhealth AS's Beneish M-Score or its related term are showing as below:

OSL:NORDH' s Beneish M-Score Range Over the Past 10 Years
Min: -3.44   Med: -2.69   Max: -1.81
Current: -3.29

During the past 6 years, the highest Beneish M-Score of Nordhealth AS was -1.81. The lowest was -3.44. And the median was -2.69.


Nordhealth AS Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Nordhealth AS's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nordhealth AS Beneish M-Score Chart

Nordhealth AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 -1.81 -2.38 -2.69 -3.44

Nordhealth AS Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.12 -3.33 -3.01 -3.44 -3.29

OSL:NORDH vs VEEV, BTSG, TEM: Beneish M-Score Comparison

For the Health Information Services subindustry, Nordhealth AS's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nordhealth AS Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nordhealth AS's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Nordhealth AS's Beneish M-Score falls into.


OSL:NORDH
75GF Score
Nordhealth AS OSL:NORDH
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nordhealth AS Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Nordhealth AS for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1058+0.528 * 1.0586+0.404 * 1.0315+0.892 * 1.0737+0.115 * 0.9946
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.192269-0.327 * 1.3486
=-3.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was kr101.0 Mil.
Revenue was 150.395 + 148.775 + 150.862 + 149.121 = kr599.2 Mil.
Gross Profit was 117.243 + 115.306 + 122.468 + 124.136 = kr479.2 Mil.
Total Current Assets was kr268.0 Mil.
Total Assets was kr814.8 Mil.
Property, Plant and Equipment(Net PPE) was kr2.9 Mil.
Depreciation, Depletion and Amortization(DDA) was kr133.0 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.0 Mil.
Total Current Liabilities was kr162.0 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.0 Mil.
Net Income was -59.671 + -56.984 + -24.683 + -33.993 = kr-175.3 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0.0 Mil.
Cash Flow from Operations was 18.893 + -5.894 + -24.974 + -6.69 = kr-18.7 Mil.
Total Receivables was kr85.0 Mil.
Revenue was 144.081 + 142.223 + 132.27 + 139.463 = kr558.0 Mil.
Gross Profit was 119.503 + 120.205 + 113.654 + 119.066 = kr472.4 Mil.
Total Current Assets was kr341.9 Mil.
Total Assets was kr978.6 Mil.
Property, Plant and Equipment(Net PPE) was kr3.4 Mil.
Depreciation, Depletion and Amortization(DDA) was kr126.3 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.0 Mil.
Total Current Liabilities was kr144.3 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(100.974 / 599.153) / (85.045 / 558.037)
=0.168528 / 0.1524
=1.1058

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(472.428 / 558.037) / (479.153 / 599.153)
=0.846589 / 0.799717
=1.0586

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (268.04 + 2.87) / 814.829) / (1 - (341.887 + 3.429) / 978.562)
=0.667525 / 0.647119
=1.0315

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=599.153 / 558.037
=1.0737

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(126.321 / (126.321 + 3.429)) / (132.999 / (132.999 + 2.87))
=0.973572 / 0.978877
=0.9946

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 599.153) / (0 / 558.037)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 161.985) / 814.829) / ((0 + 144.254) / 978.562)
=0.198796 / 0.147414
=1.3486

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-175.331 - 0 - -18.665) / 814.829
=-0.192269

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Nordhealth AS has a M-score of -3.29 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.29 mean?
Nordhealth AS (OSL:NORDH) has a Beneish M-Score of -3.29 as of Jun. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Nordhealth AS and its competitors. According to the industry distribution chart, Nordhealth AS ranks #88 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 14%.
Is Nordhealth AS's Beneish M-Score too high?
Nordhealth AS's current Beneish M-Score is -3.29. Based on the distribution chart, Nordhealth AS ranks #88 out of 630 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nordhealth AS has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's Beneish M-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nordhealth AS ranks #88 out of 630 companies for Beneish M-Score. This places Nordhealth AS in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Nordhealth AS and its competitors. Nordhealth AS's current Beneish M-Score is -3.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Based on GuruFocus' analysis, Nordhealth AS (OSL:NORDH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr38.75, compared to a current price of kr25.60 — trading 33.9% below its estimated fair value. The current Beneish M-Score is -3.29. Nordhealth AS's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Nordhealth AS (OSL:NORDH), the current Beneish M-Score is -3.29 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nordhealth AS (OSL:NORDH) Overvalued in 2026?

Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued. The current stock price of kr25.60 is trading 33.9% below its estimated GF Value™ of kr38.75. GuruFocus considers Nordhealth AS to be Significantly Undervalued.

Key valuation signals for OSL:NORDH:

  • Beneish M-Score: -3.29
  • GF Value™: kr38.75 vs. price of kr25.60 (33.9% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the OSL:NORDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nordhealth AS Business Description

Address Hasleveien 28A, Oslo, NOR, 0571
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
75GF Score

Get the complete analysis for OSL:NORDH

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr25.60
Price
kr38.75
GF Value